Human Tumor Markers

Name: Human Tumor Markers | Biology and Clinical Applications. Proceedings of the Third International Conference Lacco Ameno d'Ischia, Napoli, Italy, April 23-26, 1986
Brand: De Gruyter
Price: 269.0 EUR
Availability: OnlineOnly

Biology and Clinical Applications. Proceedings of the Third International Conference Lacco Ameno d'Ischia, Napoli, Italy, April 23-26, 1986

F. Cimino G. D. Birkmayer J. V. Klavins E. Pimentel F. Salvatore(Herausgeber*in)

De Gruyter (Verlag)

1. Auflage

Erschienen am 22. Juli 2019

XIII, 922 Seiten

E-Book

PDF mit Wasserzeichen-DRM

Systemvoraussetzungen

978-3-11-084651-5 (ISBN)

269,00 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Wasserzeichen-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Inhalt

Intro
PREFACE
CONTENTS
OPENING LECTURES
WHAT DOES "MARKER" MEAN?
BIOMARKERS AND COLORECTAL CANCER GENETICS: LYNCH SYNDROMES I AND II
THE HUMAN C-MXB PROTQ-ONCOGENE PRODUCT: IDENTIFICATION AND DETECTION IN IMMATURE LYMPHOID, ERYTHROID, AND MYELOID CELLS
MOLECULAR BIOLOGY OF TUMOR MARKERS
UPDATE ON PROTO-ONCOGENES AND HUMAN CANCER
REGULATION OF THE ADENYLATE CYCLASE ACTIVITY OF CRI4 YEAST MUTANTS BY GTP AND GDP
RESTRICTION FRAGMENT LENGTH POLYMORPHISMS (RFLPs) AS GENETIC TUMOR MARKERS
dbl: A NEW TRANSFORMING GENE ISOLATED FROM A HUMAN DIFFUSE B-CELL LYMPHOMA
DEREGULATED ONCOGENES AS MARKERS FOR MELANOMA FORMATION IN XIPHOPHORUS
GENE MODULATION BY TUMOR PROMOTERS
MOLECULAR ANALYSIS OF HTLV-III AND DEVELOPMENT OF DIAGNOTIC AND VACCINE REAGENTS FOR AIDS
Transforming properties of human cytomegalovirus
TUMOR ANTIGENS
GENOMIC MARKERS OF TUMORS
THE ENIGMA OF A HUMAN TUMOR MARKER: TPA REVISITED
THE ENIGMA OF A HUMAN TUMOR MARKER: TPA REVISITED
ALPHA-FETOPROTEIN: ITS DIAGNOSTIC SPECIFICITY AND THERAPEUTIC USE OF ITS ANTIBOBY
NUCLEOLAR ANTIGENS IN CANCER TISSUES
POSSIBLE RELATIONSHIP OF MOUSE MAMMARY TUMOR VIRUS (MMTV) TO HUMAN CYTOTROPHOBLAST
TUMOR ASSOCIATED ANTIGENS FOR INDICATION AND CONTROL OF THERAPY
TUMOR MARKERS IN THE PATIENT WITH LUNG CANCER
TPA AND CEA. 7 YEARS OF CLINICAL EXPERIENCE
BIOCHEMICAL MARKERS IN PANCREATIC CANCER DIAGNOSIS
FACTORS CONTRIBUTING TO SUPPRESSION OF TUMOUR-HOST RESPONSIVENESS
ALPHAFETOPROTEIN: THE EPITOME OF CANCER MARKERS
RESPONSES OF PATIENTS TO THEIR CARCINOMA-ASSOCIATED T AND Tn-SPECIFIC ANTIGENS
INTERMEDIATE FILAMENTS AND DESMOSOME-ASSOCIATED PROTEINS (DESMOPLAKINS) IN MORPHOLOGIC TUMOR DIAGNOSIS
IMMUNOCHEMICAL CANCER CHARACTERIZATION
CHROMOSOMES AS HUMAN TUMOR MARKERS
IMMUNODIAGNOSIS OF HUMAN CARCINOMAS USING MONOCLONAL ANTIBODIES
USE OF ANTI-HCG MONOCLONALS IN RIA AND IMMUNOHISTOCHEMISTRY
MONOCLONAL ANTIBODY DEFINED MARKERS OF HUMAN MELANOMA CELLS
A MOLECULAR ANALYSIS OF THE CARCINOEMBRYONIC ANTIGEN (CEA) BY MONOCLONAL ANTIBODIES
MHC STATUS OF PRIMARY HUMAN COLORECTAL CARCINOMA
ASSESSMENT OF TUMOR ASSOCIATED MONOCLONAL ANTIBODY IN IMMUNOTHERAPY IN SYNGENEIC MODEL
MODIFIED NUCLEOSIDES
PSEUDOURIDINE IN BIOLOGICAL FLUIDS OF TUMOR-BEARING PATIENTS
PSEUDOURIDINE EXCRETION IN EXPERIMENTAL NEOPLASIAS OF RETROVIRAL ORIGIN
HIGH RESOLUTION QUANTITATIVE RP-HPLC-UV OF NUCLEOSIDES IN RNAs, DNAs, AND mRNAs
ANALYSIS OF RIBONUCLEOSIDES IN HUMAN BODY FLUIDS AND THEIR POSSIBLE ROLE AS PATHOBIOCHEMICAL MARKERS
NUCLEOSIDE PROFILES BY HPLC-UV IN SERUM AND URINE OF CONTROLS AND CANCER PATIENTS
ABERRANT URINARY EXCRETION OF MODIFIED NUCLEOSIDES IN PATIENTS WITH VARIOUS MANIFESTATIONS OF INFECTION WITH HTLV-III/LAV
MANAGEMENT OF HUMAN LEUKEMIAS
ACTIVATION OF CELLULAR ONCOGENES FOLLOWING CHROMOSOMAL REARRANGEMENTS AS A POSSIBLE PATHOGENETIC MECHANISM IN HTLV-I POSITIVE AND NEGATIVE T-HELPER-PHENOTYPE CLL
THERAPEUTIC OPTIONS IN ACUTE LEUKEMIAS
CHARACTERIZATION OF HUMAN NON-T ACUTE LYMPHOBLASTIC LEUKAEMIA: RESULTS OF A MULTICENTRE STUDY
HUMAN INTERLEUKIN 1 (ILI) AND INTERLEUKIN 2 (IL2) CAN FUNCTION AS AUTOCRINE GROWTH FACTORS FOR SOME NEOPLASTIC HUMAN LYMPHOID CELLS
PATIENT SURVEILLANCE
LONG TERM FOLLOW-UP AND THERAPY MONITORING OF CANCER: IS THE SIMULTANEOUS DOSAGE OF CEA AND TPA USEFUL?
NEW STRATEGIES FOR FOLLOW UP OF BREAST CANCER PATIENTS USING CEA, TPA, CA 15-3 AND CA 50
SERUM LIPID SIALIC ACID (LASA) TEST IN DETECTION AND MONITORING OF MALIGNANCIES, PARANEOPLASTIC AND RHEUMATHOID SYNDROMES
CLINICAL EVALUATION OF NEW TUMOR-ASSOCIATED ANTIGENS
AN OVERVIEW OF RESULTS. FUTURE PERSPECTIVES OF RADIOIMMUNODETECTION
TUMOR IMAGING WITH RADIOLABELLED ANTIBODIES
RECEPTORS AND HORMONES
HORMONES IN LUNG CANCER
CLINICAL VALIDATION OF IMMUNORADIOMETRIC ASSAY FOR MEASURING SERUM THYROGLOBULIN IN ANTI-THYROGLOBULIN AUTOANTIBODY POSITIVE SERA IN PATIENTS WITH THYROID CANCER
ALTERATIONS OF MEMBRANE TSH-RECEPTOR IN THYROID TUMORS
BINDING OF THE ESTROGEN RECEPTOR TO DEFINED REGIONS OF THE ESTROGEN RESPONSIVE CHICKEN OVALBUMIN GENE AND CONSTRUCTION OF A CONSENSUS SEQUENCE FOR THE DNA SITE WHICH BINDS THE RECEPTOR
NEW DEVELOPMENTS IN TUMOR MARKERS AND RECEPTORS IN HEAD AND NECK TUfORS
REGULATION OF HORMONE BINDING OF 17ß-ESTRADIOL RECEPTOR BY TYROSINE PHOSPHORYLATION AND PHOSPHOTYROSINE DEPHOSPHORYLATION OF THE RECEPTOR
ENZYMES AND ISOENZYMES
SELECTIVE PROTEIN PHOSPHORYLATION BY PROTEIN KINASE C IN CELL ACTIVATION
PROTEIN KINASE ACTIVITIES OF NORMAL AND TRANSFORMED LYMPHOCYTES
DEFICIENCY OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE IN HUMAN LEUKEMIA: BIOCHEMICAL ASPECTS AND CLINICAL IMPLICATIONS
THE ROLE OF MULTIPLE FORMS OF ALKALINE PHOSPHATASE IN CANCER DETECTION AND MONITORING
GLUTATHIONE TRANSFERASE AS A TUMOR MARKER IN HUMAN BREAST CARCINOMA
CANCER-RELATED CHANGES IN CREATINE KINASE ISOENZYMES AND VARIANTS
CLINICAL SIGNIFICANCE OF A REARRANGED HEXOKINASE ISOZYMES EXPRESSION IN NEOPLASTIC PHENOTYPE: THE ASTROCYTOMA MODEL
ANTIOXYGENIC ENZYMES AS TUMOR MARKERS: A CRITICAL REASSESSMENT OF THE RESPECTIVE ROLES OF SUPEROXIDE DISMUTASE AND GLUTATHIONE PEROXIDASE
NOVEL ASPECTS OF THE HUMAN ALDOLASE GENE FAMILY AND ITS EXPRESSION IN TUMOR CELLS
AUTHOR INDEX
SUBJECT INDEX

Systemvoraussetzungen

Als PDF speichern Als Link merken